Ebola vaccine - Wikipedia
WEBApproved. rVSV-ZEBOV. VSV-EBOV or rVSV-ZEBOV, sold under the brand name Ervebo, is a vaccine based on the vesicular stomatitis virus which was genetically modified to express a surface glycoprotein of Zaire Ebola virus. [16][17] In November 2019, the European Commission granted a conditional marketing authorization. [18] .
Ebola Vaccine Product Information | Ebola | CDC - Centers for …
WEBMay 1, 2024 · There is a safe and effective vaccine that has been approved by the U.S. Food and Drug Administration (FDA) to prevent Ebola disease, called ERVEBO ®. ERVEBO ® is only effective against one of the viruses that causes Ebola disease. ERVEBO® should only be given to patients who meet specific criteria.
Ebola virus disease: Vaccines - World Health Organization (WHO)
WEBJan 11, 2020 · Is there a vaccine against Ebola virus disease? Have these vaccines been used before? Why are the vaccines not given to everyone at risk in endemic areas? Who is eligible for the vaccine? Can children, pregnant and breastfeeding women be vaccinated? Can the vaccine cause adverse effects?
First FDA-approved vaccine for the prevention of Ebola virus …
WEBThe U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in...
Ebola Vaccine VIS | Vaccines & Immunizations | CDC
WEBJun 30, 2022 · Ebola vaccine is a live virus vaccine that is administered as a single dose by injection into a muscle. The vaccine contains a weakened strain of the vesicular stomatitis virus that has been altered to contain a gene from the Ebola virus.
Use of Ebola Vaccines — Worldwide, 2021–2023 | MMWR
WEBApr 25, 2024 · Two licensed vaccines are currently available against Orthoebolavirus zairense, the virus that causes Ebola: the 1-dose rVSVΔG-ZEBOV-GP (ERVEBO [Merck]) and the 2-dose regimen of Ad26.ZEBOV and MVA-BN-Filo (Zabdeno/Mvabea [Johnson & …
Randomized Trial of Vaccines for Zaire Ebola Virus Disease
WEBDec 14, 2022 · Two vaccine strategies to prevent EVD — the recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing the surface glycoprotein of Zaire ebolavirus (ZEBOV; the rVSVΔG-ZEBOV-GP...
Ebola Vaccines | NIAID: National Institute of Allergy and Infectious ...
WEBCurrently there are no licensed vaccines to prevent Ebola virus disease. However, multiple investigational Ebola vaccines have been tested in numerous clinical trials around the world. NIAID has supported the development of various candidates, including the rVSV-ZEBOV vaccine developed by Merck.
Ebola virus vaccines - World Health Organization (WHO)
WEBJan 24, 2020 · Two Ebola virus vaccines are currently undergoing phase 1 clinical trials: ChAd3-EBO-Z (GSK Biologicals/NIAID) and rVSV-ZEBOV (NewLink/Merck). Timelines for the availability of phase 1 data and key milestones for the phase 2/3 testing were presented.
Ebola virus disease - World Health Organization (WHO)
WEBApr 20, 2023 · Vaccines to protect against some types of Ebola have been used to control the spread of Ebola in outbreaks. Other vaccines are in development. Early supportive care with rehydration and the treatment of symptoms improves survival.
Skip to content